nodes	percent_of_prediction	percent_of_DWPC	metapath
Everolimus—CYP3A4—Esomeprazole—Barrett's esophagus	0.28	0.629	CbGbCtD
Everolimus—CYP3A4—Omeprazole—Barrett's esophagus	0.165	0.371	CbGbCtD
Everolimus—MTOR—epithelium—Barrett's esophagus	0.00776	0.185	CbGeAlD
Everolimus—MTOR—smooth muscle tissue—Barrett's esophagus	0.00748	0.178	CbGeAlD
Everolimus—FKBP1A—epithelium—Barrett's esophagus	0.00698	0.167	CbGeAlD
Everolimus—FKBP1A—smooth muscle tissue—Barrett's esophagus	0.00673	0.161	CbGeAlD
Everolimus—MTOR—digestive system—Barrett's esophagus	0.00591	0.141	CbGeAlD
Everolimus—FKBP1A—digestive system—Barrett's esophagus	0.00531	0.127	CbGeAlD
Everolimus—Candida infection—Esomeprazole—Barrett's esophagus	0.00225	0.00448	CcSEcCtD
Everolimus—Candida infection—Omeprazole—Barrett's esophagus	0.00225	0.00448	CcSEcCtD
Everolimus—Fluid retention—Omeprazole—Barrett's esophagus	0.00224	0.00446	CcSEcCtD
Everolimus—Fluid retention—Esomeprazole—Barrett's esophagus	0.00224	0.00446	CcSEcCtD
Everolimus—Rash maculo-papular—Esomeprazole—Barrett's esophagus	0.00214	0.00427	CcSEcCtD
Everolimus—Rash maculo-papular—Omeprazole—Barrett's esophagus	0.00214	0.00427	CcSEcCtD
Everolimus—Neoplasm—Esomeprazole—Barrett's esophagus	0.00213	0.00424	CcSEcCtD
Everolimus—Bladder pain—Omeprazole—Barrett's esophagus	0.00213	0.00424	CcSEcCtD
Everolimus—Mouth ulceration—Esomeprazole—Barrett's esophagus	0.00213	0.00424	CcSEcCtD
Everolimus—Bladder pain—Esomeprazole—Barrett's esophagus	0.00213	0.00424	CcSEcCtD
Everolimus—Urine output increased—Omeprazole—Barrett's esophagus	0.00213	0.00424	CcSEcCtD
Everolimus—Urine output increased—Esomeprazole—Barrett's esophagus	0.00213	0.00424	CcSEcCtD
Everolimus—Mouth ulceration—Omeprazole—Barrett's esophagus	0.00213	0.00424	CcSEcCtD
Everolimus—Neoplasm—Omeprazole—Barrett's esophagus	0.00213	0.00424	CcSEcCtD
Everolimus—Lymphadenopathy—Esomeprazole—Barrett's esophagus	0.00201	0.00399	CcSEcCtD
Everolimus—Lymphadenopathy—Omeprazole—Barrett's esophagus	0.00201	0.00399	CcSEcCtD
Everolimus—Blood alkaline phosphatase increased—Omeprazole—Barrett's esophagus	0.00197	0.00392	CcSEcCtD
Everolimus—Blood alkaline phosphatase increased—Esomeprazole—Barrett's esophagus	0.00197	0.00392	CcSEcCtD
Everolimus—Polyuria—Esomeprazole—Barrett's esophagus	0.00195	0.00388	CcSEcCtD
Everolimus—Polyuria—Omeprazole—Barrett's esophagus	0.00195	0.00388	CcSEcCtD
Everolimus—Gastroenteritis—Omeprazole—Barrett's esophagus	0.00193	0.00384	CcSEcCtD
Everolimus—Gastroenteritis—Esomeprazole—Barrett's esophagus	0.00193	0.00384	CcSEcCtD
Everolimus—Hepatic failure—Esomeprazole—Barrett's esophagus	0.0019	0.00379	CcSEcCtD
Everolimus—Hepatic failure—Omeprazole—Barrett's esophagus	0.0019	0.00379	CcSEcCtD
Everolimus—Hot flush—Omeprazole—Barrett's esophagus	0.00183	0.00364	CcSEcCtD
Everolimus—Hot flush—Esomeprazole—Barrett's esophagus	0.00183	0.00364	CcSEcCtD
Everolimus—Menopausal symptoms—Esomeprazole—Barrett's esophagus	0.00181	0.00361	CcSEcCtD
Everolimus—Menopausal symptoms—Omeprazole—Barrett's esophagus	0.00181	0.00361	CcSEcCtD
Everolimus—Renal impairment—Esomeprazole—Barrett's esophagus	0.0018	0.00358	CcSEcCtD
Everolimus—Renal impairment—Omeprazole—Barrett's esophagus	0.0018	0.00358	CcSEcCtD
Everolimus—Hypoglycaemia—Omeprazole—Barrett's esophagus	0.00175	0.00349	CcSEcCtD
Everolimus—Hypoglycaemia—Esomeprazole—Barrett's esophagus	0.00175	0.00349	CcSEcCtD
Everolimus—CYP3A4—digestive system—Barrett's esophagus	0.00174	0.0414	CbGeAlD
Everolimus—Hyponatraemia—Omeprazole—Barrett's esophagus	0.00172	0.00342	CcSEcCtD
Everolimus—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.00172	0.00342	CcSEcCtD
Everolimus—Pain in extremity—Omeprazole—Barrett's esophagus	0.00171	0.00341	CcSEcCtD
Everolimus—Pain in extremity—Esomeprazole—Barrett's esophagus	0.00171	0.00341	CcSEcCtD
Everolimus—Migraine—Omeprazole—Barrett's esophagus	0.00168	0.00335	CcSEcCtD
Everolimus—Migraine—Esomeprazole—Barrett's esophagus	0.00168	0.00335	CcSEcCtD
Everolimus—Irritability—Esomeprazole—Barrett's esophagus	0.00163	0.00325	CcSEcCtD
Everolimus—Irritability—Omeprazole—Barrett's esophagus	0.00163	0.00325	CcSEcCtD
Everolimus—Blood creatinine increased—Esomeprazole—Barrett's esophagus	0.0016	0.00319	CcSEcCtD
Everolimus—Blood creatinine increased—Omeprazole—Barrett's esophagus	0.0016	0.00319	CcSEcCtD
Everolimus—Dry skin—Esomeprazole—Barrett's esophagus	0.00157	0.00312	CcSEcCtD
Everolimus—Dry skin—Omeprazole—Barrett's esophagus	0.00157	0.00312	CcSEcCtD
Everolimus—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.00156	0.00311	CcSEcCtD
Everolimus—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.00156	0.00311	CcSEcCtD
Everolimus—Hypokalaemia—Omeprazole—Barrett's esophagus	0.00156	0.0031	CcSEcCtD
Everolimus—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.00156	0.0031	CcSEcCtD
Everolimus—Breast disorder—Esomeprazole—Barrett's esophagus	0.00155	0.00308	CcSEcCtD
Everolimus—Breast disorder—Omeprazole—Barrett's esophagus	0.00155	0.00308	CcSEcCtD
Everolimus—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.00154	0.00307	CcSEcCtD
Everolimus—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00154	0.00307	CcSEcCtD
Everolimus—Gastritis—Esomeprazole—Barrett's esophagus	0.00151	0.00302	CcSEcCtD
Everolimus—Gastritis—Omeprazole—Barrett's esophagus	0.00151	0.00302	CcSEcCtD
Everolimus—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00151	0.00301	CcSEcCtD
Everolimus—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.00151	0.00301	CcSEcCtD
Everolimus—Muscular weakness—Esomeprazole—Barrett's esophagus	0.00151	0.00301	CcSEcCtD
Everolimus—Muscular weakness—Omeprazole—Barrett's esophagus	0.00151	0.00301	CcSEcCtD
Everolimus—Abdominal distension—Esomeprazole—Barrett's esophagus	0.00149	0.00296	CcSEcCtD
Everolimus—Abdominal distension—Omeprazole—Barrett's esophagus	0.00149	0.00296	CcSEcCtD
Everolimus—Dysphagia—Esomeprazole—Barrett's esophagus	0.00148	0.00295	CcSEcCtD
Everolimus—Influenza—Omeprazole—Barrett's esophagus	0.00148	0.00295	CcSEcCtD
Everolimus—Dysphagia—Omeprazole—Barrett's esophagus	0.00148	0.00295	CcSEcCtD
Everolimus—Influenza—Esomeprazole—Barrett's esophagus	0.00148	0.00295	CcSEcCtD
Everolimus—Bronchospasm—Omeprazole—Barrett's esophagus	0.00145	0.0029	CcSEcCtD
Everolimus—Bronchospasm—Esomeprazole—Barrett's esophagus	0.00145	0.0029	CcSEcCtD
Everolimus—Pancreatitis—Omeprazole—Barrett's esophagus	0.00145	0.00289	CcSEcCtD
Everolimus—Pancreatitis—Esomeprazole—Barrett's esophagus	0.00145	0.00289	CcSEcCtD
Everolimus—Angina pectoris—Esomeprazole—Barrett's esophagus	0.00144	0.00287	CcSEcCtD
Everolimus—Angina pectoris—Omeprazole—Barrett's esophagus	0.00144	0.00287	CcSEcCtD
Everolimus—Pancytopenia—Esomeprazole—Barrett's esophagus	0.0014	0.0028	CcSEcCtD
Everolimus—Pancytopenia—Omeprazole—Barrett's esophagus	0.0014	0.0028	CcSEcCtD
Everolimus—Dysuria—Esomeprazole—Barrett's esophagus	0.00138	0.00275	CcSEcCtD
Everolimus—Neutropenia—Omeprazole—Barrett's esophagus	0.00138	0.00275	CcSEcCtD
Everolimus—Dysuria—Omeprazole—Barrett's esophagus	0.00138	0.00275	CcSEcCtD
Everolimus—Neutropenia—Esomeprazole—Barrett's esophagus	0.00138	0.00275	CcSEcCtD
Everolimus—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.00137	0.00274	CcSEcCtD
Everolimus—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.00137	0.00274	CcSEcCtD
Everolimus—Pollakiuria—Omeprazole—Barrett's esophagus	0.00137	0.00272	CcSEcCtD
Everolimus—Pollakiuria—Esomeprazole—Barrett's esophagus	0.00137	0.00272	CcSEcCtD
Everolimus—Erectile dysfunction—Omeprazole—Barrett's esophagus	0.00136	0.00271	CcSEcCtD
Everolimus—Erectile dysfunction—Esomeprazole—Barrett's esophagus	0.00136	0.00271	CcSEcCtD
Everolimus—Weight decreased—Esomeprazole—Barrett's esophagus	0.00134	0.00266	CcSEcCtD
Everolimus—Weight decreased—Omeprazole—Barrett's esophagus	0.00134	0.00266	CcSEcCtD
Everolimus—Infestation NOS—Omeprazole—Barrett's esophagus	0.00132	0.00263	CcSEcCtD
Everolimus—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00132	0.00263	CcSEcCtD
Everolimus—Infestation—Esomeprazole—Barrett's esophagus	0.00132	0.00263	CcSEcCtD
Everolimus—Infestation—Omeprazole—Barrett's esophagus	0.00132	0.00263	CcSEcCtD
Everolimus—Renal failure—Esomeprazole—Barrett's esophagus	0.0013	0.00258	CcSEcCtD
Everolimus—Renal failure—Omeprazole—Barrett's esophagus	0.0013	0.00258	CcSEcCtD
Everolimus—Stomatitis—Omeprazole—Barrett's esophagus	0.00129	0.00256	CcSEcCtD
Everolimus—Jaundice—Omeprazole—Barrett's esophagus	0.00129	0.00256	CcSEcCtD
Everolimus—Stomatitis—Esomeprazole—Barrett's esophagus	0.00129	0.00256	CcSEcCtD
Everolimus—Jaundice—Esomeprazole—Barrett's esophagus	0.00129	0.00256	CcSEcCtD
Everolimus—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.00128	0.00255	CcSEcCtD
Everolimus—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.00128	0.00255	CcSEcCtD
Everolimus—Conjunctivitis—Omeprazole—Barrett's esophagus	0.00128	0.00255	CcSEcCtD
Everolimus—Urinary tract infection—Omeprazole—Barrett's esophagus	0.00128	0.00255	CcSEcCtD
Everolimus—Haematuria—Esomeprazole—Barrett's esophagus	0.00126	0.0025	CcSEcCtD
Everolimus—Haematuria—Omeprazole—Barrett's esophagus	0.00126	0.0025	CcSEcCtD
Everolimus—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.00125	0.00248	CcSEcCtD
Everolimus—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.00125	0.00248	CcSEcCtD
Everolimus—Epistaxis—Esomeprazole—Barrett's esophagus	0.00124	0.00248	CcSEcCtD
Everolimus—Epistaxis—Omeprazole—Barrett's esophagus	0.00124	0.00248	CcSEcCtD
Everolimus—Sinusitis—Omeprazole—Barrett's esophagus	0.00124	0.00246	CcSEcCtD
Everolimus—Sinusitis—Esomeprazole—Barrett's esophagus	0.00124	0.00246	CcSEcCtD
Everolimus—Rhinitis—Esomeprazole—Barrett's esophagus	0.00119	0.00236	CcSEcCtD
Everolimus—Rhinitis—Omeprazole—Barrett's esophagus	0.00119	0.00236	CcSEcCtD
Everolimus—Hepatitis—Omeprazole—Barrett's esophagus	0.00118	0.00236	CcSEcCtD
Everolimus—Hepatitis—Esomeprazole—Barrett's esophagus	0.00118	0.00236	CcSEcCtD
Everolimus—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.00118	0.00235	CcSEcCtD
Everolimus—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.00118	0.00235	CcSEcCtD
Everolimus—Hallucination—Esomeprazole—Barrett's esophagus	0.00118	0.00235	CcSEcCtD
Everolimus—Hallucination—Omeprazole—Barrett's esophagus	0.00118	0.00235	CcSEcCtD
Everolimus—Pharyngitis—Omeprazole—Barrett's esophagus	0.00117	0.00234	CcSEcCtD
Everolimus—Pharyngitis—Esomeprazole—Barrett's esophagus	0.00117	0.00234	CcSEcCtD
Everolimus—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.00117	0.00233	CcSEcCtD
Everolimus—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.00117	0.00233	CcSEcCtD
Everolimus—Oedema peripheral—Omeprazole—Barrett's esophagus	0.00117	0.00232	CcSEcCtD
Everolimus—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.00117	0.00232	CcSEcCtD
Everolimus—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.00116	0.00232	CcSEcCtD
Everolimus—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.00116	0.00232	CcSEcCtD
Everolimus—Urethral disorder—Omeprazole—Barrett's esophagus	0.00116	0.00231	CcSEcCtD
Everolimus—Urethral disorder—Esomeprazole—Barrett's esophagus	0.00116	0.00231	CcSEcCtD
Everolimus—Eye disorder—Esomeprazole—Barrett's esophagus	0.00111	0.0022	CcSEcCtD
Everolimus—Eye disorder—Omeprazole—Barrett's esophagus	0.00111	0.0022	CcSEcCtD
Everolimus—Flushing—Esomeprazole—Barrett's esophagus	0.0011	0.00219	CcSEcCtD
Everolimus—Flushing—Omeprazole—Barrett's esophagus	0.0011	0.00219	CcSEcCtD
Everolimus—Immune system disorder—Omeprazole—Barrett's esophagus	0.00107	0.00213	CcSEcCtD
Everolimus—Immune system disorder—Esomeprazole—Barrett's esophagus	0.00107	0.00213	CcSEcCtD
Everolimus—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00107	0.00212	CcSEcCtD
Everolimus—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00107	0.00212	CcSEcCtD
Everolimus—Chills—Omeprazole—Barrett's esophagus	0.00106	0.00212	CcSEcCtD
Everolimus—Chills—Esomeprazole—Barrett's esophagus	0.00106	0.00212	CcSEcCtD
Everolimus—Alopecia—Omeprazole—Barrett's esophagus	0.00105	0.00208	CcSEcCtD
Everolimus—Alopecia—Esomeprazole—Barrett's esophagus	0.00105	0.00208	CcSEcCtD
Everolimus—Mental disorder—Esomeprazole—Barrett's esophagus	0.00104	0.00207	CcSEcCtD
Everolimus—Mental disorder—Omeprazole—Barrett's esophagus	0.00104	0.00207	CcSEcCtD
Everolimus—FKBP1A—TGF-beta Receptor Signaling—BMP4—Barrett's esophagus	0.00104	0.0904	CbGpPWpGaD
Everolimus—Malnutrition—Omeprazole—Barrett's esophagus	0.00103	0.00205	CcSEcCtD
Everolimus—Malnutrition—Esomeprazole—Barrett's esophagus	0.00103	0.00205	CcSEcCtD
Everolimus—Flatulence—Omeprazole—Barrett's esophagus	0.00102	0.00202	CcSEcCtD
Everolimus—Flatulence—Esomeprazole—Barrett's esophagus	0.00102	0.00202	CcSEcCtD
Everolimus—Dysgeusia—Omeprazole—Barrett's esophagus	0.00101	0.00201	CcSEcCtD
Everolimus—Dysgeusia—Esomeprazole—Barrett's esophagus	0.00101	0.00201	CcSEcCtD
Everolimus—Back pain—Omeprazole—Barrett's esophagus	0.000997	0.00198	CcSEcCtD
Everolimus—Back pain—Esomeprazole—Barrett's esophagus	0.000997	0.00198	CcSEcCtD
Everolimus—Muscle spasms—Omeprazole—Barrett's esophagus	0.000991	0.00197	CcSEcCtD
Everolimus—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000991	0.00197	CcSEcCtD
Everolimus—Vision blurred—Esomeprazole—Barrett's esophagus	0.000971	0.00193	CcSEcCtD
Everolimus—Vision blurred—Omeprazole—Barrett's esophagus	0.000971	0.00193	CcSEcCtD
Everolimus—Tremor—Omeprazole—Barrett's esophagus	0.000966	0.00192	CcSEcCtD
Everolimus—Tremor—Esomeprazole—Barrett's esophagus	0.000966	0.00192	CcSEcCtD
Everolimus—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.000956	0.0019	CcSEcCtD
Everolimus—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.000956	0.0019	CcSEcCtD
Everolimus—Anaemia—Omeprazole—Barrett's esophagus	0.000953	0.0019	CcSEcCtD
Everolimus—Anaemia—Esomeprazole—Barrett's esophagus	0.000953	0.0019	CcSEcCtD
Everolimus—Agitation—Esomeprazole—Barrett's esophagus	0.000947	0.00189	CcSEcCtD
Everolimus—Agitation—Omeprazole—Barrett's esophagus	0.000947	0.00189	CcSEcCtD
Everolimus—Angioedema—Omeprazole—Barrett's esophagus	0.000942	0.00188	CcSEcCtD
Everolimus—Angioedema—Esomeprazole—Barrett's esophagus	0.000942	0.00188	CcSEcCtD
Everolimus—Malaise—Omeprazole—Barrett's esophagus	0.000929	0.00185	CcSEcCtD
Everolimus—Malaise—Esomeprazole—Barrett's esophagus	0.000929	0.00185	CcSEcCtD
Everolimus—Leukopenia—Omeprazole—Barrett's esophagus	0.000922	0.00184	CcSEcCtD
Everolimus—Leukopenia—Esomeprazole—Barrett's esophagus	0.000922	0.00184	CcSEcCtD
Everolimus—Palpitations—Esomeprazole—Barrett's esophagus	0.000911	0.00181	CcSEcCtD
Everolimus—Palpitations—Omeprazole—Barrett's esophagus	0.000911	0.00181	CcSEcCtD
Everolimus—Cough—Esomeprazole—Barrett's esophagus	0.000899	0.00179	CcSEcCtD
Everolimus—Cough—Omeprazole—Barrett's esophagus	0.000899	0.00179	CcSEcCtD
Everolimus—Hypertension—Esomeprazole—Barrett's esophagus	0.00089	0.00177	CcSEcCtD
Everolimus—Hypertension—Omeprazole—Barrett's esophagus	0.00089	0.00177	CcSEcCtD
Everolimus—Arthralgia—Esomeprazole—Barrett's esophagus	0.000877	0.00175	CcSEcCtD
Everolimus—Myalgia—Esomeprazole—Barrett's esophagus	0.000877	0.00175	CcSEcCtD
Everolimus—Chest pain—Esomeprazole—Barrett's esophagus	0.000877	0.00175	CcSEcCtD
Everolimus—Arthralgia—Omeprazole—Barrett's esophagus	0.000877	0.00175	CcSEcCtD
Everolimus—Chest pain—Omeprazole—Barrett's esophagus	0.000877	0.00175	CcSEcCtD
Everolimus—Myalgia—Omeprazole—Barrett's esophagus	0.000877	0.00175	CcSEcCtD
Everolimus—Anxiety—Esomeprazole—Barrett's esophagus	0.000874	0.00174	CcSEcCtD
Everolimus—Anxiety—Omeprazole—Barrett's esophagus	0.000874	0.00174	CcSEcCtD
Everolimus—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000871	0.00173	CcSEcCtD
Everolimus—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000871	0.00173	CcSEcCtD
Everolimus—Discomfort—Omeprazole—Barrett's esophagus	0.000867	0.00173	CcSEcCtD
Everolimus—Discomfort—Esomeprazole—Barrett's esophagus	0.000867	0.00173	CcSEcCtD
Everolimus—Dry mouth—Esomeprazole—Barrett's esophagus	0.000858	0.00171	CcSEcCtD
Everolimus—Dry mouth—Omeprazole—Barrett's esophagus	0.000858	0.00171	CcSEcCtD
Everolimus—Infection—Omeprazole—Barrett's esophagus	0.000836	0.00166	CcSEcCtD
Everolimus—Infection—Esomeprazole—Barrett's esophagus	0.000836	0.00166	CcSEcCtD
Everolimus—Shock—Omeprazole—Barrett's esophagus	0.000827	0.00165	CcSEcCtD
Everolimus—Shock—Esomeprazole—Barrett's esophagus	0.000827	0.00165	CcSEcCtD
Everolimus—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000825	0.00164	CcSEcCtD
Everolimus—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000825	0.00164	CcSEcCtD
Everolimus—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000824	0.00164	CcSEcCtD
Everolimus—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000824	0.00164	CcSEcCtD
Everolimus—Tachycardia—Omeprazole—Barrett's esophagus	0.000821	0.00163	CcSEcCtD
Everolimus—Tachycardia—Esomeprazole—Barrett's esophagus	0.000821	0.00163	CcSEcCtD
Everolimus—Skin disorder—Omeprazole—Barrett's esophagus	0.000817	0.00163	CcSEcCtD
Everolimus—Skin disorder—Esomeprazole—Barrett's esophagus	0.000817	0.00163	CcSEcCtD
Everolimus—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000813	0.00162	CcSEcCtD
Everolimus—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000813	0.00162	CcSEcCtD
Everolimus—Anorexia—Esomeprazole—Barrett's esophagus	0.000802	0.0016	CcSEcCtD
Everolimus—Anorexia—Omeprazole—Barrett's esophagus	0.000802	0.0016	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000766	0.00153	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000766	0.00153	CcSEcCtD
Everolimus—Insomnia—Esomeprazole—Barrett's esophagus	0.000761	0.00151	CcSEcCtD
Everolimus—Insomnia—Omeprazole—Barrett's esophagus	0.000761	0.00151	CcSEcCtD
Everolimus—Paraesthesia—Omeprazole—Barrett's esophagus	0.000755	0.0015	CcSEcCtD
Everolimus—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000755	0.0015	CcSEcCtD
Everolimus—Dyspnoea—Omeprazole—Barrett's esophagus	0.00075	0.00149	CcSEcCtD
Everolimus—Dyspnoea—Esomeprazole—Barrett's esophagus	0.00075	0.00149	CcSEcCtD
Everolimus—Somnolence—Esomeprazole—Barrett's esophagus	0.000748	0.00149	CcSEcCtD
Everolimus—Somnolence—Omeprazole—Barrett's esophagus	0.000748	0.00149	CcSEcCtD
Everolimus—Dyspepsia—Omeprazole—Barrett's esophagus	0.00074	0.00147	CcSEcCtD
Everolimus—Dyspepsia—Esomeprazole—Barrett's esophagus	0.00074	0.00147	CcSEcCtD
Everolimus—Decreased appetite—Omeprazole—Barrett's esophagus	0.000731	0.00146	CcSEcCtD
Everolimus—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000731	0.00146	CcSEcCtD
Everolimus—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000726	0.00145	CcSEcCtD
Everolimus—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000726	0.00145	CcSEcCtD
Everolimus—Fatigue—Esomeprazole—Barrett's esophagus	0.000725	0.00144	CcSEcCtD
Everolimus—Fatigue—Omeprazole—Barrett's esophagus	0.000725	0.00144	CcSEcCtD
Everolimus—Constipation—Esomeprazole—Barrett's esophagus	0.000719	0.00143	CcSEcCtD
Everolimus—Pain—Omeprazole—Barrett's esophagus	0.000719	0.00143	CcSEcCtD
Everolimus—Constipation—Omeprazole—Barrett's esophagus	0.000719	0.00143	CcSEcCtD
Everolimus—Pain—Esomeprazole—Barrett's esophagus	0.000719	0.00143	CcSEcCtD
Everolimus—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000693	0.00138	CcSEcCtD
Everolimus—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000693	0.00138	CcSEcCtD
Everolimus—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000688	0.00137	CcSEcCtD
Everolimus—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000688	0.00137	CcSEcCtD
Everolimus—Body temperature increased—Omeprazole—Barrett's esophagus	0.000665	0.00132	CcSEcCtD
Everolimus—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000665	0.00132	CcSEcCtD
Everolimus—Abdominal pain—Omeprazole—Barrett's esophagus	0.000665	0.00132	CcSEcCtD
Everolimus—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000665	0.00132	CcSEcCtD
Everolimus—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.00062	0.00123	CcSEcCtD
Everolimus—Hypersensitivity—Omeprazole—Barrett's esophagus	0.00062	0.00123	CcSEcCtD
Everolimus—Asthenia—Omeprazole—Barrett's esophagus	0.000603	0.0012	CcSEcCtD
Everolimus—Asthenia—Esomeprazole—Barrett's esophagus	0.000603	0.0012	CcSEcCtD
Everolimus—Pruritus—Omeprazole—Barrett's esophagus	0.000595	0.00118	CcSEcCtD
Everolimus—Pruritus—Esomeprazole—Barrett's esophagus	0.000595	0.00118	CcSEcCtD
Everolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—PTGS2—Barrett's esophagus	0.000582	0.0508	CbGpPWpGaD
Everolimus—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000575	0.00115	CcSEcCtD
Everolimus—Diarrhoea—Omeprazole—Barrett's esophagus	0.000575	0.00115	CcSEcCtD
Everolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—HGF—Barrett's esophagus	0.000565	0.0493	CbGpPWpGaD
Everolimus—Dizziness—Omeprazole—Barrett's esophagus	0.000556	0.00111	CcSEcCtD
Everolimus—Dizziness—Esomeprazole—Barrett's esophagus	0.000556	0.00111	CcSEcCtD
Everolimus—Vomiting—Omeprazole—Barrett's esophagus	0.000535	0.00106	CcSEcCtD
Everolimus—Vomiting—Esomeprazole—Barrett's esophagus	0.000535	0.00106	CcSEcCtD
Everolimus—Rash—Esomeprazole—Barrett's esophagus	0.00053	0.00106	CcSEcCtD
Everolimus—Rash—Omeprazole—Barrett's esophagus	0.00053	0.00106	CcSEcCtD
Everolimus—Dermatitis—Omeprazole—Barrett's esophagus	0.00053	0.00105	CcSEcCtD
Everolimus—Dermatitis—Esomeprazole—Barrett's esophagus	0.00053	0.00105	CcSEcCtD
Everolimus—Headache—Omeprazole—Barrett's esophagus	0.000527	0.00105	CcSEcCtD
Everolimus—Headache—Esomeprazole—Barrett's esophagus	0.000527	0.00105	CcSEcCtD
Everolimus—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000514	0.0448	CbGpPWpGaD
Everolimus—MTOR—BDNF signaling pathway—CRTC1—Barrett's esophagus	0.000506	0.0442	CbGpPWpGaD
Everolimus—Nausea—Esomeprazole—Barrett's esophagus	0.0005	0.000995	CcSEcCtD
Everolimus—Nausea—Omeprazole—Barrett's esophagus	0.0005	0.000995	CcSEcCtD
Everolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—APC—Barrett's esophagus	0.00042	0.0366	CbGpPWpGaD
Everolimus—MTOR—ErbB1 downstream signaling—SLC9A1—Barrett's esophagus	0.000326	0.0284	CbGpPWpGaD
Everolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000295	0.0258	CbGpPWpGaD
Everolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000295	0.0258	CbGpPWpGaD
Everolimus—MTOR—IL2 signaling events mediated by PI3K—RELA—Barrett's esophagus	0.000277	0.0242	CbGpPWpGaD
Everolimus—MTOR—Wnt Signaling Pathway Netpath—APC—Barrett's esophagus	0.00027	0.0236	CbGpPWpGaD
Everolimus—MTOR—Wnt Signaling Pathway Netpath—PPARG—Barrett's esophagus	0.000261	0.0227	CbGpPWpGaD
Everolimus—MTOR—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HGF—Barrett's esophagus	0.000258	0.0225	CbGpPWpGaD
Everolimus—MTOR—TSLP Signaling Pathway—RELA—Barrett's esophagus	0.000229	0.02	CbGpPWpGaD
Everolimus—MTOR—TSLP Signaling Pathway—CXCL8—Barrett's esophagus	0.000216	0.0188	CbGpPWpGaD
Everolimus—MTOR—CDC42 signaling events—APC—Barrett's esophagus	0.000213	0.0186	CbGpPWpGaD
Everolimus—MTOR—SREBP signalling—PPARG—Barrett's esophagus	0.000208	0.0181	CbGpPWpGaD
Everolimus—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000205	0.0179	CbGpPWpGaD
Everolimus—MTOR—RANKL/RANK Signaling Pathway—RELA—Barrett's esophagus	0.000202	0.0176	CbGpPWpGaD
Everolimus—MTOR—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—APC—Barrett's esophagus	0.000191	0.0167	CbGpPWpGaD
Everolimus—FKBP1A—Spinal Cord Injury—PTGS2—Barrett's esophagus	0.000189	0.0165	CbGpPWpGaD
Everolimus—MTOR—IL12-mediated signaling events—RELA—Barrett's esophagus	0.000188	0.0164	CbGpPWpGaD
Everolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000188	0.0164	CbGpPWpGaD
Everolimus—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000185	0.0161	CbGpPWpGaD
Everolimus—FKBP1A—Spinal Cord Injury—CXCL8—Barrett's esophagus	0.000184	0.016	CbGpPWpGaD
Everolimus—MTOR—Oncostatin M Signaling Pathway—RELA—Barrett's esophagus	0.000177	0.0154	CbGpPWpGaD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.00017	0.0148	CbGpPWpGaD
Everolimus—MTOR—Leptin signaling pathway—RELA—Barrett's esophagus	0.000158	0.0137	CbGpPWpGaD
Everolimus—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000152	0.0133	CbGpPWpGaD
Everolimus—MTOR—LKB1 signaling events—TP53—Barrett's esophagus	0.000142	0.0124	CbGpPWpGaD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000129	0.0112	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—CDKN2A—Barrett's esophagus	0.000125	0.0109	CbGpPWpGaD
Everolimus—MTOR—BDNF signaling pathway—APC—Barrett's esophagus	0.00012	0.0104	CbGpPWpGaD
Everolimus—MTOR—ErbB Signaling Pathway—TP53—Barrett's esophagus	0.000119	0.0103	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—CXCL8—Barrett's esophagus	0.000113	0.00989	CbGpPWpGaD
Everolimus—FKBP1A—Spinal Cord Injury—TP53—Barrett's esophagus	0.000113	0.00983	CbGpPWpGaD
Everolimus—MTOR—Oncostatin M Signaling Pathway—TP53—Barrett's esophagus	0.000102	0.00891	CbGpPWpGaD
Everolimus—MTOR—AMPK Signaling—TP53—Barrett's esophagus	9.74e-05	0.00849	CbGpPWpGaD
Everolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	9.72e-05	0.00848	CbGpPWpGaD
Everolimus—MTOR—BDNF signaling pathway—RELA—Barrett's esophagus	9.35e-05	0.00815	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	8.3e-05	0.00724	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	8.08e-05	0.00704	CbGpPWpGaD
Everolimus—FKBP1A—Disease—SLC9A1—Barrett's esophagus	7.97e-05	0.00695	CbGpPWpGaD
Everolimus—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	7.96e-05	0.00694	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	7.93e-05	0.00691	CbGpPWpGaD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	7.67e-05	0.00669	CbGpPWpGaD
Everolimus—MTOR—B Cell Activation—RELA—Barrett's esophagus	7.34e-05	0.0064	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—GAST—Barrett's esophagus	7.28e-05	0.00635	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—TP53—Barrett's esophagus	6.96e-05	0.00607	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—CDKN2A—Barrett's esophagus	5.98e-05	0.00522	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—RELA—Barrett's esophagus	5.76e-05	0.00502	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—CXCL8—Barrett's esophagus	5.43e-05	0.00473	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—RELA—Barrett's esophagus	5.4e-05	0.00471	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	5.21e-05	0.00454	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—SST—Barrett's esophagus	4.99e-05	0.00435	CbGpPWpGaD
Everolimus—MTOR—Disease—SLC9A1—Barrett's esophagus	4.48e-05	0.00391	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—GAST—Barrett's esophagus	4.09e-05	0.00357	CbGpPWpGaD
Everolimus—FKBP1A—Disease—APC—Barrett's esophagus	3.77e-05	0.00329	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—TP53—Barrett's esophagus	3.33e-05	0.0029	CbGpPWpGaD
Everolimus—MTOR—Immune System—HGF—Barrett's esophagus	3.09e-05	0.0027	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—RELA—Barrett's esophagus	3.08e-05	0.00269	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—RELA—Barrett's esophagus	2.96e-05	0.00258	CbGpPWpGaD
Everolimus—FKBP1A—Disease—PTGS2—Barrett's esophagus	2.86e-05	0.0025	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—SST—Barrett's esophagus	2.81e-05	0.00245	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—APC—Barrett's esophagus	2.64e-05	0.0023	CbGpPWpGaD
Everolimus—MTOR—Disease—APC—Barrett's esophagus	2.12e-05	0.00185	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—RELA—Barrett's esophagus	2.06e-05	0.0018	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CXCL8—Barrett's esophagus	1.94e-05	0.00169	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PTGES—Barrett's esophagus	1.82e-05	0.00159	CbGpPWpGaD
Everolimus—MTOR—Immune System—RELA—Barrett's esophagus	1.79e-05	0.00156	CbGpPWpGaD
Everolimus—MTOR—Disease—PTGS2—Barrett's esophagus	1.61e-05	0.0014	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—APC—Barrett's esophagus	1.48e-05	0.00129	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	1.38e-05	0.0012	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—TP53—Barrett's esophagus	1.19e-05	0.00104	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—RELA—Barrett's esophagus	1.16e-05	0.00101	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CXCL8—Barrett's esophagus	1.09e-05	0.000953	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	9.95e-06	0.000868	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TP53—Barrett's esophagus	6.71e-06	0.000585	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PPARG—Barrett's esophagus	4.54e-06	0.000396	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	3.57e-06	0.000312	CbGpPWpGaD
